{
    "2021-02-19": [
        [
            {
                "time": "",
                "original_text": "康希诺生物持续加码研发去年预亏超4亿 核心疫苗产品有望年内上市挽业绩颓势",
                "features": {
                    "keywords": [
                        "康希诺生物",
                        "研发",
                        "预亏",
                        "核心疫苗",
                        "上市",
                        "业绩颓势"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}